Skip to Content

Newsletter No. 48 -- July 2001

ITEMS OF INTEREST TO THE IMAGING RESEARCH COMMUNITY:

CIP Web Site: http://www.cancer.gov/bip

Meeting Announcements:

  1. HiRES 2001 Meeting: High Resolution Imaging in Small Animals: Instrumentation, Applications and Animal Handling, Rockville, Maryland, September 9-11, 2001
    URL: http://www.ornl.gov/HiRes2001/
  2. Medical Image PerceptionIX Conference, Airlie House, Warrenton, VA September 20-23, 2001 Topics among others: Detection errors and optimal human and machine "Visual search"; Observer models; Computer-aided fusion of image features and computer-aided detection and diagnosis; Soft-copy displays: technological and human factors; and Assessment methodologies, e.g., ROC analysis with reader random effects.
    URL: http://www.radiology.arizona.edu/krupinski/mips/mipcix.html
  3. Academy of Molecular Imaging Meeting October 24-28, 2001.
    URL: http://www.ami-imaging.org

NIH

  1. REVISED PHS 398 AND PHS 2590 NOW AVAILABLE (NOT-OD-01-049) All applications received on or after January 10, 2002 must use the new forms. URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-01-049.html
  2. The "NCI Initiatives - Extraordinary Opportunities" Web site has been updated. It features How to Propose an Extraordinary Opportunity for Investment.
    URL: http://www.cancer.gov/initiatives/index.html
  3. CANCER INTERVENTION AND SURVEILLANCE MODELING NETWORK (CISNET) (NCI) (RFA-CA-02-010)
    Letter of Intent Receipt Date: October 9, 2001;
    Application Receipt Date: November 13, 2001
    The Division of Cancer Control and Population Sciences, NCI, invites applications to support collaborative research using simulation and other modeling techniques to describe the impact of interventions (i.e., primary prevention, screening, and treatment) in population-based settings. The primary goals of this research are:
    1) to determine the impact of cancer control interventions on observed trends in incidence and/or mortality; and
    2) to determine if recommended interventions are having their expected population impact by examining discrepancies between controlled cancer intervention study results and the population experience.
    URL: http://grants.nih.gov/grants/guide/rfa-files/rfa-ca-02-010.html
  4. NHLBI INNOVATIVE RESEARCH GRANT PROGRAM (NHLBI) (RFA-HL-01-016)
    Letter of Intent Receipt Dates: One month prior to application receipt;
    Application Receipt Dates: Applications will be accepted every four (4) months during fiscal year 2002 on the following receipt dates: October 18, 2001; February 15, 2002; June 18, 2002.
    The purpose of this Request for Applications is to provide limited support, not to exceed $100,000 in direct costs per year for up to two years, for innovative research activities to test imaginative ideas and explore new approaches to heart, lung, and blood diseases and sleep disorders that utilize existing data sets or existing biological specimen collections whether obtained through NHLBI support or not.
    URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-01-016.html
  5. NHLBI MENTORED MINORITY FACULTY DEVELOPMENT AWARD (K01) (RFA-HL-01-020) NHLBI SHORT-TERM TRAINING FOR MINORITY STUDENTS PROGRAM (T35)
    Letter of Intent Receipt Date: July 18, 2001;
    Application Receipt Date: August 15, 2001
    Applications may be submitted by domestic, for-profit and non-profit organizations, public and private, such as universities, colleges, hospitals, laboratories, units of State and local governments, and eligible agencies of the Federal government. RFA-HL-01-020 will use the NHLBI Mentored Minority Faculty Development Award (K01) award mechanism of support. RFA-HL-01-021 will use the National Institutes of Health (NIH) Short-Term Training Grant (T35) award mechanism.
    URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-01-020.html
    URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-01-021.html
  6. HIGH END INSTRUMENTATION PROGRAM (NCRR) (RFA-RR-01-004)
    The National Center for Research Resources (NCRR) announces a new program for the support of research instrumentation. Awards will be made for up to a maximum of $2.0 million in direct costs for a single major item of advanced equipment. This RFA will use the National Institutes of Health (NIH) S10 grant mechanism.
    URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-RR-01-004.html
  7. SPECIALIZED PROGRAMS OF RESEARCH EXCELLENCE (SPOREs) IN HUMAN CANCER FOR THE YEAR 2002 (NCI) (PAR-01-110)
    Letter of Intent Receipt Dates:
    Breast and Gynecological Cancer SPOREs: December 1, 2001
    Lung, Leukemia, and Myeloma Cancer SPOREs: April 1, 2002
    Prostate and Genitourinary Cancer SPOREs: August 1, 2002
    Application Receipt Dates:
    Breast and Gynecological Cancer SPOREs: February 1, 2002
    Lung, Leukemia, and Myeloma Cancer SPOREs: June 1, 2002
    Prostate and Genitourinary Cancer SPOREs: October 1, 2002
    The Organ Systems Branch of the Office of the Deputy Director for Extramural Science at the National Cancer Institute (NCI) invites grant applications (P50) for Specialized Programs of Research Excellence (SPORE) in organ-specific cancers.
    URL: http://grants.nih.gov/grants/guide/pa-files/PAR-01-110.html
  8. RAPID ACCESS TO PREVENTIVE INTERVENTION DEVELOPMENT - "RAPID" - ADDENDUM (NCI) (NOT-CA-01-014)
    Receipt date for requests has been changed to October 1, 2001.
    Investigators are further notified that the contact person and web site for the RAPID program have changed, see http://cancer.gov/rapid.
    The Rapid Access to Preventive Intervention Development (RAPID) program makes available to academic investigators the preclinical and early clinical drug development contract resources of NCI's Division of Cancer Prevention. The goal of the RAPID program is the expeditious movement of novel molecules and concepts from the laboratory to the clinic for clinical trials of efficacy.
    URL: http://grants.nih.gov/grants/guide/notice-files/NOT-CA-01-014.html
  9. APPLICATIONS OF INNOVATIVE TECHNOLOGIES FOR THE MOLECULAR ANALYSIS OF CANCER: PHASED INNOVATION AWARD (NCI)(PAR-01-106)
    Letter of Intent Date: June 15, 2001; October 17, 2001; February 14, 2002; June 10, 2002; October 18, 2002; February 14, 2003; and June 16, 2003
    Application Receipt Date: July 20, 2001; November 21, 2001; March 21, 2002; July 22, 2002; November 22, 2002; March 21, 2003; and July 21, 2003
    The National Cancer Institute (NCI) invites applications for research projects to evaluate the utility and pilot the application of molecular analysis technologies in studies relevant to cancer research.
    URL: http://grants.nih.gov/grants/guide/pa-files/PAR-01-106.html
  10. APPLICATIONS OF INNOVATIVE TECHNOLOGIES FOR THE MOLECULAR ANALYSIS OF CANCER: SBIR/STTR (NCI) (companion announcement to above)
    URL: http://grants.nih.gov/grants/guide/pa-files/PAR-01-107.html
  11. FUNCTIONAL ATLAS OF ORPHAN NUCLEAR RECEPTORS (NIDDK) (RFA-DK-01-026)
    Letter of intent: October 17, 2001;
    Application Receipt Date: November 19, 2001
    The purpose of this initiative is to develop a Functional Atlas of Orphan Nuclear Receptors emphasizing understanding and cataloging of structure, tissue distribution, specificity, and function. The funding instrument to be used for this program will be a Research Program-Cooperative Agreement (U19), an assistance mechanism (rather than an acquisition mechanism). Pilot projects (e.g. Imaging, Ligand Discovery, Data Mining) may be requested for investigators in an area deemed important to the collaborative project, to add elements where gaps exist, or to add investigators with critical knowledge or expertise. These need not be from individuals having a research background in the area of the collaborative program. These projects may not exceed $75,000 in annual direct costs and must be limited to no more than three such projects.
    URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-01-026.html
  12. TRIALS ASSESSING INNOVATIVE STRATEGIES TO IMPROVE CLINICAL PRACTICE THROUGH GUIDELINES IN HEART, LUNG, AND BLOOD DISEASES (NHLBI) (HL-01-011)
    Letter of Intent Receipt Date: September 12, 2001;
    Application Receipt Date: October 12, 2001
    The National Heart, Lung, and Blood Institute invites applications for research project (R01) grants to evaluate interventions that represent innovative strategies that can be employed in clinical practice to improve implementation of national, evidence-based clinical practice guidelines for the treatment of heart, lung and blood diseases and conditions.
    URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-01-011.html
  13. Joint DMS/NIGMS Initiative to Support Research Grants in the Area of Mathematical Biology Primary Sponsor: National Science Foundation (NSF 01-128)
    DEADLINE: October 5, 2001
    The Division of Mathematical Sciences in the Directorate for Mathematical and Physical Sciences at the National Science Foundation and the National Institute of General Medical Sciences at the National Institutes of Health plan to support research in mathematics and statistics related to mathematical biology research. This competition is designed to encourage new collaborations at the interface, as well as to support existing ones. DMS and NIGMS anticipate making 20-25 awards totaling about $6 million, in fiscal year 2002. The projected range is from $100,000 to $500,000 per award per year, with durations of 4-5 years. Awards made from this competition may be made by either DMS or NIGMS, at the option of the agencies, not the grantee.
    URL: http://www.nsf.gov/cgi-bin/getpub?nsf01128

Other Government Agenices

  1. NSF Industry/University Cooperative Research Centers Program (I/UCRC) (NSF 01-116)
    Letter of Intent: July 31, 2001. Thereafter, June 30 and December 31 Annually
    Planning Grant: March 31 and September 30 Annually
    Center Proposal: 18 Months after award of a planning grant.
    The Industry/University Cooperative Research Centers (I/UCRCs) program develops long-term partnerships among industry, academe, and government. The centers are catalyzed by a small investment from the National Science Foundation (NSF) and are primarily supported by industry center members, with NSF taking a supporting role in their development and evolution.
    URL: http://www.nsf.gov/cgi-bin/getpub?nsf01116

Other Agenices

  1. Within Our Reach (WOR) Program (National Alliance of Breast Cancer Organizations)
    Deadline (letters of inquiry): August 10, 2001.
    Within Our Reach (WOR) is a grantmaking and technical assistance program established by the National Alliance of Breast Cancer Organizations (NABCO). Evidence suggests that more widespread use of regular screening mammography has been a major contributor to recent improvements in breast cancer survival rates. WOR will accomplish its objective by awarding one-year grants of up to $50,000 on an annual basis to programs that provide, or link medically underserved women to, breast cancer education and screening services.
    URL: http://www.nabco.org/whatsnew/fund/within2.html
  2. RSNA Advanced Course in Grant Writing
    Applications due July 15, 2002
    Meeting dates (attend all): September 14-16, 2001; October 5-6, 2001; April 5-6, 2002; June 7-8, 2002
    Contact: Peggy Belcastro, (630) 368,3758, belcastr@rsna.org
    URL: http://www.rsna.org
  3. Society of Cardiovascular and Interventional Radiology - Cardiovascular and Interventional Radiology Research and Education Foundation
    a. Academic Transition Award -
    Application Deadline November 1st
    The Academic Transition Award is designed for interventional radiologists over the age of 40 who have recently begun academic careers after spending several years in private or non-academic practice. The award is intended to facilitate the establishment of a record of independent research by the investigator in order to promote a successful academic career. One award of up to $25,000 will be made each year for a pilot or seed grant project that tests a new idea or helps support a new area or direction of research.
    b. Pilot Research Grant Program -
    Application Deadline: May 1st and November 1st
    The CIRREF Pilot Research Grant Program (formerly the Research Grant Program) funds research identified as important to the advancement of cardiovascular and interventional radiology and patient care. Awards of up to $25,000 are intended to support pilot or seed grant type projects that test a new idea or help support a new area or direction of research.
    c. ACRIN Protocol Development Award -
    Applications accepted at any time throughout the year
    This program is designed to provide investigators an incentive and support to pursue the American College of Radiology Imaging Network (ACRIN) for funding of their research ideas. The award is intended to increase the number of submissions of high quality protocols related to the field of cardiovascular and interventional radiology.
    Awards are available in two phases:
    1) an initial Phase I award of $1000, payable to the applicant for the submission of a CIRREF-approved Summary Protocol to ACRIN; and
    2) a Phase II supplemental award of up to $2500, provided to support the further development of an ACRIN Research Strategy Committee-approved Summary Protocol into a final protocol submission.
    d. Travel Scholarship Award -
    Application Deadline: 2 months prior to selected meeting
    The Travel Scholarship is designed to provide residents and fellows an opportunity to attend specialized research meetings related to their research in cardiovascular and interventional radiology. The award of $1000 is intended to off-set the costs of their travel.
    URL: http://www.cirref.org/grant/grant.htm
  4. Society of the Sigma XI - Grants-in-Aid of Research Guidelines and Online Application for Grants-in-Aid of Research
    Submission deadlines: March 15 and October 15
    The application is only available two months prior to the deadline. Please check the web site after August 15, 2001.
    URL: http://www.sigmaxi.org/
  5. 2001 CaP CURE Research Award
    Applications will be accepted August 13, 2001 through October 12, 2001. Applications may be postmarked no later than October 12, 2001.
    CaP CURE will continue to fund outstanding and novel basic science that is the cornerstone in the discovery of a cure for prostate cancer. CaP CURE will favor research applications focused on translational and clinical programs that will benefit patients with advanced prostate cancer in the near term.
    URL: http://www.capcure.org/research/index.html

___________________________________

The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.

If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (js95x@nih.gov).

Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7440
Tel: 301 496 9531
Fax: 301 480 3507